Auckland PHO Staff Update | Due to personal reasons, Tracey Gilling-Senilebakula is no longer working at Auckland PHO. We will be able to let our network know this week how we will be providing Practice Management Support to Auckland PHO practices. If you require help and troubleshooting support, please continue to contact ashley@auckandpho.co.nz or ring the Auckland PHO office on 379 4022. |
Ukraine Special Policy Visa Holders | Ukraine persons holding a 2022 Special Ukraine Visa are eligible for a one off 45-minute health assessment fully funded by Te Whatu Ora. This funding has been extended until 31 December 2025. Uptake is voluntary. Those who wish to access this service do not need to provide proof that they are 2022 Special Ukraine Visa Holders. They only need to tell the practice that they have arrived in New Zealand under the 2022 Special Ukraine Policy Visa – Please ensure the Practice’s Front Desk team know about this. The funded assessment includes the following:
Managing Test Results
Funding (ex GST)
Claiming
Please see HealthPathways for more detail. For more information click here. |
COVID-19 Vaccine Updates | A reminder that from 7 March, 2024: o COVID-19 Comirnaty Omicron XBB.1.5 (30mcg) vaccine product replaces the previous COVID-19 Comirnaty mRNA-CV (30mcg) monovalent vaccine and COVID-19 Comirnaty mRNA-CV Bivalent (15mcg/15mcg) o COVID-19 Comirnaty Omicron XBB.1.5 (30mcg) vaccine product is approved to be administered for primary and additional doses o COVID-19 Comirnaty mRNA-CV Bivalent (15mcg/15mcg) has been delisted and should not be used to record additional doses.
Any clinical queries contact IMAC on 0800 466 863. |
Changes to COVID-19 Testing | Also a reminder, that from March 7 2024 the:
o The COVID-19 testing plan and guidance documents in their current state are no longer fit for purpose and these documents will be removed from the Te Whatu Ora website. o On 4 March 2024, COVID-19 testing content that remains relevant for certain sector groups was transferred to the COVID-19 chapter of the Communicable Diseases Manual and/or HealthPathways. o Redundant information that is no longer needed for other sector groups was not transferred. If you have any questions about this update, please email COVID-19testing@health.govt.nz |
Barbara Stevens |Tumu Whakarae/CEO
Comentários